Covered recipient · General Payments record
ERICA HOBSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2021–2024
$9,427.31
- Reported across 414 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $708.66 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SOBI, INC | $246.00 | 2 |
| Incyte Corporation | $124.78 | 1 |
| E.R. Squibb & Sons, L.L.C. | $116.88 | 1 |
| Acerta Pharma LLC | $113.08 | 1 |
| ABBVIE INC. | $42.00 | 2 |
| Genmab U.S., Inc. | $24.09 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.26 | 1 |
| Tempus AI, Inc | $20.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.69 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107342130 | CMS |
| ABBVIE INC. | $19.31 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107342132 | CMS |
| AstraZeneca Pharmaceuticals LP | $113.08 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104723793 | CMS |
| E.R. Squibb & Sons, L.L.C. | $116.88 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101235173 | CMS |
| Genmab U.S., Inc. | $24.09 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126835590 | CMS |
| Incyte Corporation | $124.78 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141320889 | CMS |
| Novartis Pharmaceuticals Corporation | $21.26 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086845775 | CMS |
| SOBI, INC | $123.89 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141430085 | CMS |
| SOBI, INC | $122.11 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141430543 | CMS |
| Tempus AI, Inc | $20.57 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150182335 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.